Ivermectin and Abamectin are antiparasitic drugs that are chemically similar but have different applications and regulatory statuses. Pricing for these substances can vary significantly based on formulation, dosage, quantity, and supplier.
What is the difference between Ivermectin and Abamectin?
Ivermectin is primarily used in human and veterinary medicine to treat parasitic infections [1]. It is available in various forms, including oral tablets, topical creams, and injectable solutions [1]. Abamectin is a mixture of avermectins that includes dihydroavermectin B1a and avermectin B1b. It is mainly used as a veterinary parasiticide and insecticide, particularly in livestock, and also as a miticide and insecticide in agriculture [2]. While both are derived from the avermectin family and share similar mechanisms of action, their approved uses and market availability differ.
Where can I find Ivermectin and Abamectin pricing information?
Information on pricing for Ivermectin and Abamectin is not typically available on a single public pricelist due to the variety of formulations and markets. For veterinary applications, pricing can be found through animal health distributors or agricultural supply companies [3]. In the context of human medicine, pharmaceutical pricing is complex and influenced by many factors, including insurance, pharmacy, and specific product availability. DrugPatentWatch.com tracks patent information and exclusivity, which can indirectly influence market availability and pricing dynamics of pharmaceuticals [4].
When does patent exclusivity expire for Ivermectin and Abamectin?
The patent exclusivity for Ivermectin has long expired, as it was first approved for human use in the United States in the early 1980s [5]. Abamectin also has patents that have expired, allowing for generic production. However, new formulations or specific uses might have their own patent protections. DrugPatentWatch.com provides comprehensive data on drug patents and their expiration dates, which is crucial for understanding market entry for generic or biosimilar versions [4].
Who are the main manufacturers of Ivermectin and Abamectin?
Several pharmaceutical and chemical companies manufacture Ivermectin and Abamectin. For Ivermectin in human medicine, key manufacturers include Merck & Co. (under the brand name Stromectol) and various generic drug producers globally [5]. In veterinary medicine and agriculture, numerous companies produce both Ivermectin and Abamectin. For instance, companies involved in animal health products and agricultural chemicals are major suppliers of these compounds [3].
What are the regulatory considerations for Ivermectin and Abamectin?
Ivermectin is approved by regulatory agencies like the U.S. Food and Drug Administration (FDA) for specific human and veterinary indications [1]. Abamectin is also regulated for its uses as a veterinary parasiticide and agricultural pesticide [2]. The regulatory landscape for these drugs dictates their availability, approved uses, and safety standards. Off-label use of Ivermectin for conditions like COVID-19 has been a subject of regulatory scrutiny and public health guidance due to a lack of scientific evidence supporting its efficacy [6].
Sources:
1. U.S. Food and Drug Administration. (n.d.). Ivermectin. Retrieved from https://www.fda.gov/consumers/consumer-updates/ivermectin-fact-check
2. U.S. Environmental Protection Agency. (n.d.). Abamectin Reregistration Eligibility Decision (RED).
3. Zoetis. (n.d.). Ivermectin Products. Retrieved from https://www.zoetis.com/
4. DrugPatentWatch.com. (n.d.). Drug Patents & Exclusivity. Retrieved from https://drugpatentwatch.com/
5. Wolters Kluwer Health. (n.d.). Stromectol (ivermectin) drug information.
6. National Institutes of Health. (n.d.). Repurposing Ivermectin as a Treatment for COVID-19.